Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Concise Method
Treatment of cells with neutralizing antibodies
Ask a
question
Favorite
HepG2-LV-SiDcR3 cells were treated with neutralizing antibodies of DR4 and DR5 for 1 h and incubated with TRAIL (100 ng/mL) for 24 h.
Copyright and License information: ©2017 Liang et al. This work is published and licensed by Dove Medical Press Limited
The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
